The distinct effects of gastrin on proximal versus distal gastric cancers are consistent with the distinct epidemiology and behavior of tumors at these two anatomical sites, and emphasizes the importance of pathological descriptions clearly distinguishing the corpus and the antrum as separate tumor sites. This evidence concerns the gene GAST and gastric cancer.